Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
Last Updated Last Updated : Aug 10, 2020 08:15 AM IST | Source: Moneycontrol.com

Prospects for US business and leadership in respiratory therapies make Cipla attractive

Cipla's US revenues clocked a sequential improvement to about $135 million, backed by a ramp-up in the generic version of gProventil HFA

Anubhav Sahu

To view the full content of this article, you have to be a Pro:

  • Already a Moneycontrol Pro subscriber?
  • Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:

What's included:

  • Ad free experience across Platforms
  • 230+ exclusive stories per month
  • Sharpest Opinions & Actionable Insights
  • Exclusive Research & Expert Technical Analysis
  • Daily Newsletter
  • 20+ Technical Picks every week
  • Recovery Tracker
  • Exclusive webinars on varied topics
  • Weekly wrap up and much more!!!